SCHEMBL8431982

SCHEMBL8431982

CCc1ccc2scc(CC#N)c2c1

nearest known ligand 0.63

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 0.63
MTNR1A P48039 5/20 0.51
HTR5A P47898 1/20 0.35
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34
CA2 P00918 1/20 0.34
KDM4E B2RXH2 1/20 0.33
MTNR1B P49286 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10224643 0.83 MTNR1A (0.62) CYP2A6MTNR1AHTR5AKEAP1NFE2L2
SCHEMBL2947128 0.78 CYP2A6 (1.00) CYP2A6KEAP1NFE2L2CA2
SCHEMBL8549384 0.78 CYP2A6 (0.67) CYP2A6KEAP1NFE2L2CA2
SCHEMBL7141321 0.78 CYP2A6 (0.67) CYP2A6MTNR1AKEAP1NFE2L2CA2
SCHEMBL8431821 0.76 MTNR1A (0.59) CYP2A6MTNR1AHTR5ACA2MTNR1B
SCHEMBL10064416 0.75 MTNR1A (0.53) CYP2A6MTNR1AHTR5AKEAP1NFE2L2
Hydrochloric Acid SCHEMBL8882742 0.75 MTNR1A (0.58) CYP2A6MTNR1AHTR5ACA2MTNR1B
SCHEMBL8435916 0.74 KEAP1 (0.64) MTNR1AKEAP1NFE2L2KDM4EMTNR1B
SCHEMBL8037709 0.74 MTNR1A (0.56) CYP2A6MTNR1AHTR5ACA2MTNR1B
SCHEMBL274426 0.73 CYP2A6 (0.60) CYP2A6CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0721938-B1 Alkyl(hetero)cyclic compounds, process for their preparation and pharmaceutical compositions containing them ADIR (FR) 1999-12-08 EP disclosed
US-5780512-A MELATONINERGIC ADIR ET COMPAGNIE (FR) 1998-07-14 US disclosed
US-5693665-A TREATING MELATONINERGIC DISORDERS ADIR ET COMPAGNIE (FR) 1997-12-02 US disclosed
EP-0721938-A1 Alkyl(hetero)cyclic compounds, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1996-07-17 EP disclosed